Why HOCl Product Claims Depend on Use Case, Labeling and Documentation

By Full Alliance Group, Inc. · Company newsroom

Hypochlorous acid, commonly abbreviated as HOCl, is often discussed as a single ingredient category. In practice, responsible product communication depends on the specific formulation, intended use, label, documentation package and regulatory context.

That distinction matters for HOCl businesses, formulators, private-label partners and commercial buyers. A statement that may be appropriate for one product and use site may not be appropriate for another.

HOCl Is a Chemistry Platform, Not a One-Size-Fits-All Claim

HOCl is identified by the U.S. Food and Drug Administration in its environmental-decision inventory for Food Contact Notification No. 2198 as hypochlorous acid, CAS Reg. No. 7790-92-3. The same FDA inventory entry links to environmental assessment and Finding of No Significant Impact materials for that notification.

That does not mean every HOCl product has the same permitted use, concentration, labeling or food-contact status. Food-contact notifications, disinfectant labels, skincare positioning and industrial sanitation programs each depend on their own facts.

For example, an HOCl product intended for a food-contact application should be discussed in relation to the applicable notification, manufacturer or supplier identity, intended use conditions and limitations. A disinfectant product, by contrast, should be discussed in relation to its registered label, use sites, organisms or pathogens where applicable, directions and contact time.

Concentration, Water Quality and Contact Time Matter

HOCl product discussions often focus on broad phrases such as “gentle,” “powerful,” “clean,” or “disinfecting.” Those phrases can be incomplete without technical context.

Key details may include:

• available free chlorine concentration;
• pH and water chemistry;
• product stability and shelf-life parameters;
• intended surface, skin or use environment;
• whether the use involves food-contact surfaces;
• required wet contact time for disinfection claims; and
• exact label directions and limitations.

The Centers for Disease Control and Prevention advises users to read and follow disinfectant label directions, keep surfaces wet for the stated contact time, avoid mixing products and not apply disinfection products directly to skin. EPA guidance for registered disinfectants also emphasizes reading the product label, using the product according to its directions, matching the product to the intended use site and pest or pathogen, and following the required contact time. EPA’s pesticide-labeling Q&A states that using a registered sanitizer product for less than the contact time specified on the product label would be inconsistent with labeling.

In plain terms: a product’s claim should follow the product’s label and evidence, not the reputation of the broader ingredient category.

Food-Contact Status Is Product- and Use-Specific

FDA’s environmental-decision inventory entry for FCN No. 2198 shows how specific food-contact documentation can be. The entry identifies hypochlorous acid and links related environmental assessment and Finding of No Significant Impact materials.

FDA’s effective Food Contact Substance Notification inventory also states that an FCN is effective only for the manufacturer or supplier identified in the notification. For formulators and buyers, that means food-contact language should be tied to the relevant notification, use conditions, manufacturer or supplier identity and documentation. It is not enough to say that HOCl appears in a food-contact context somewhere; the question is whether the specific product and intended use are supported.

How Pure AquaOx Fits This Discipline

Pure AquaOx manufactures HOCl solutions for skincare, sanitizing and disinfection applications, and its website presents HOCl products incorporating nanobubble technology. Its commercial sales channel includes direct quote requests at PureAquaOx.com and is structured as a business inquiry route rather than a conventional consumer product catalog.

That business-to-business structure makes documentation especially important. Commercial buyers may need different support depending on whether they are evaluating a skincare application, a sanitizer, a disinfectant use case or a private-label program. In each case, the responsible approach is to match the discussion to product specifications, labeling, intended use and applicable regulatory requirements.

A Practical Rule for HOCl Communication

For HOCl product teams, the safest editorial and commercial habit is simple: avoid category-wide shortcuts.

Instead of asking, “What can HOCl do?” ask:

1. What is the exact product?
2. What is its concentration and chemistry profile?
3. What is the intended use site?
4. What does the label say?
5. What documentation supports that use?
6. Does the claim involve food contact, disinfection, skincare or another regulated context?

Those questions help keep marketing language aligned with the product record. They also help buyers compare HOCl systems on the facts that matter: formulation, documentation, labeling and fit for the intended application.

Sources: FDA Inventory of Environmental Impact Decisions for Food Contact Substance Notifications, FCN No. 2198; FDA effective Food Contact Substance Notification inventory; CDC cleaning and disinfecting guidance; EPA selected registered disinfectants guidance; EPA pesticide-labeling Q&A.

Company-Sponsored Information and Securities Disclaimer

This material is company-sponsored information provided by Full Alliance Group, Inc. (OTC: FAGI) for general informational purposes. It reflects the Company’s perspective and is not independent investment research. It does not constitute investment, legal, or tax advice, an offer to sell securities, or a solicitation to purchase securities. Any securities offering, if undertaken, will be conducted through appropriate offering documents and in accordance with applicable securities laws.

Forward-Looking Statements

This material may contain forward-looking statements concerning Full Alliance Group, Inc. and its subsidiaries, brands, products, and business initiatives. These statements include expectations regarding business development, product launches, manufacturing capacity, sales, revenue, profitability, financing, acquisitions, partnerships, technology development, regulatory approvals, and anticipated milestones. Words such as “anticipate,” “believe,” “expect,” “intend,” “plan,” “project,” “estimate,” “may,” “will,” and similar expressions may identify forward-looking statements, although not all such statements contain these words.

Forward-looking statements reflect management’s expectations and assumptions as of the date made and involve known and unknown risks and uncertainties. Actual results may differ materially from those expressed or implied. Relevant risks include the availability and cost of capital; dilution from future financing; the ability to execute business plans and integrate acquisitions; customer demand and market acceptance; competition; manufacturing, supply-chain, and distribution constraints; product quality and liability; regulatory requirements affecting supplements, wellness products, HOCl products, payments, digital assets, and securities activities; reliance on third-party providers; cybersecurity and data privacy; and general economic conditions.